Raito Kogyo Co., Ltd.
Raito Kogyo Co., Ltd. (1926.T) Financial Performance & Income Statement Overview
Explore the financials of Raito Kogyo Co., Ltd. (1926.T), including yearly and quarterly data on income, cash flow, and balance sheets.
Raito Kogyo Co., Ltd. (1926.T) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Raito Kogyo Co., Ltd. 1926.T financial performance.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $32.37B | $34.12B | $29.55B | $25.42B |
| Cost of Revenue | $25.88B | $27.17B | $23.05B | $20.26B |
| Gross Profit | $6.49B | $6.95B | $6.49B | $5.16B |
| Gross Profit Ratio | $0.20 | $0.20 | $0.22 | $0.20 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $3.10B | $3.03B | $3.09B | $3.06B |
| Operating Expenses | $3.10B | $3.03B | $3.09B | $3.06B |
| Total Costs & Expenses | $28.98B | $30.20B | $26.14B | $23.32B |
| Interest Income | $27.00M | $30.00M | $29.00M | $35.00M |
| Interest Expense | $25.00M | $29.00M | $25.00M | $24.00M |
| Depreciation & Amortization | $791.00M | $722.50M | $735.50M | $698.00M |
| EBITDA | $4.33B | $4.64B | $4.14B | $2.96B |
| EBITDA Ratio | $0.13 | $0.14 | $0.14 | $0.12 |
| Operating Income | $3.39B | $3.92B | $3.40B | $2.10B |
| Operating Income Ratio | $0.10 | $0.11 | $0.12 | $0.08 |
| Other Income/Expenses (Net) | $869.00M | $191.00M | -$42.00M | $139.00M |
| Income Before Tax | $4.26B | $4.11B | $3.36B | $2.24B |
| Income Before Tax Ratio | $0.13 | $0.12 | $0.11 | $0.09 |
| Income Tax Expense | $964.00M | $1.25B | $1.12B | $739.00M |
| Net Income | $3.29B | $2.86B | $2.26B | $1.51B |
| Net Income Ratio | $0.10 | $0.08 | $0.08 | $0.06 |
| EPS | $73.10 | $62.54 | $48.32 | $31.69 |
| Diluted EPS | $73.10 | $62.54 | $48.32 | $31.69 |
| Weighted Avg Shares Outstanding | $45.05M | $46.05M | $46.71M | $47.68M |
| Weighted Avg Shares Outstanding (Diluted) | $44.52M | $46.05M | $46.71M | $47.68M |
Over the past four quarters, Raito Kogyo Co., Ltd. demonstrated steady revenue growth, increasing from $25.42B in Q1 2024 to $32.37B in Q4 2024. Operating income reached $3.39B in Q4 2024, maintaining a consistent 10% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $4.33B, reflecting operational efficiency. Net income rose to $3.29B, with EPS at $73.10. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan